A Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

NCT03994549 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Dual GLP-1/GLP-2 Receptor agonists

Sponsor

Zealand Pharma